Cookson Peirce & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Cookson Peirce & Co's AUPH Position: Q3 2026 in Review
Cookson Peirce & Co reduced its Aurinia Pharmaceuticals (AUPH) stake by 2.5% in Q3 2026, selling an estimated $42.3K and leaving 102,341 shares worth $1.66M. The position accounts for 0.06% of the portfolio, ranked #157.
Cookson Peirce & Co first reported a position in AUPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.82M in Q1 2026. 276 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Cookson Peirce & Co held 102,341 shares of Aurinia Pharmaceuticals worth $1.66M as of Q3 2026.
- Cookson Peirce & Co sold 2,651 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $42.3K.
- Aurinia Pharmaceuticals made up 0.06% of Cookson Peirce & Co's portfolio in Q3 2026, its #157 holding.
- Cookson Peirce & Co first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Cookson Peirce & Co's Aurinia Pharmaceuticals position peaked at $1.82M in Q1 2026.
- 276 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.